Circulating tumour cells (CTCs) can provide critical insights in cancer research by enabling duel analysis of CTC-DNA and ctDNA from a single blood tube, as well as RNA and protein analyses that advance precision oncology. ANGLE’s proprietary Parsortix® system offers an optimal solution for capturing and harvesting CTCs directly from whole blood, supported by over 100 peer-reviewed publications across 42 independent cancer centres and 24 cancer types. Alongside supplying the Parsortix system for research use, ANGLE delivers specialised clinical and translational services through its accredited laboratories, supporting biomarker discovery, drug development and customised liquid biopsy assay validation.
Secure your 1:1 appointment below and learn more about:
Location
Orlando, USA
Date
November 1-3, 2025
ANGLE attendees
Request a meeting with the ANGLE team at ISLB the 7th Annual Congress
Neil Darroch
Senior Sales Manager - Product Solutions
Neil Darroch is a Senior Sales Manager at ANGLE, taking care of Europe and the eastern United States. With nearly two decades of experience across multinational and startup medical diagnostic companies, Neil is passionate about science and works closely with our clinical and research partners.
Neil Darroch
Senior Sales Manager - Product Solutions
Neil Darroch is a Senior Sales Manager at ANGLE, taking care of Europe and the eastern United States. With nearly two decades of experience across multinational and startup medical diagnostic companies, Neil is passionate about science and works closely with our clinical and research partners.